| Literature DB >> 22348150 |
Tai-Chih Kuo1, Chung-Ho Wang, Hsiu-Chen Lin, Yuan-Hau Lin, Matthew Lin, Chun-Mao Lin, Hsien-Shou Kuo.
Abstract
Water (H(2)O) is the most abundant and important molecule of life. Natural water contains small amount of heavy isotopes. Previously, few animal model studies have shown that the isotopic composition of body water could play important roles in physiology and pathophysiology. Here we study the stable isotopic ratios of hydrogen (δ(2)H) and oxygen (δ(18)O) in human blood plasma. The stable isotopic ratio is defined and determined by δ(sample) = [(R(sample)/R(STD))-1] * 1000, where R is the molar ratio of rare to abundant, for example, (18)O/(16)O. We observe that the δ(2)H and the δ(18)O in human blood plasma are associated with the human renal functions. The water isotope ratios of the δ(2)H and δ(18)O in human blood plasma of the control subjects are comparable to those of the diabetes subjects (with healthy kidney), but are statistically higher than those of the end stage renal disease subjects (p<0.001 for both ANOVA and Student's t-test). In addition, our data indicate the existence of the biological homeostasis of water isotopes in all subjects, except the end stage renal disease subjects under the haemodialysis treatment. Furthermore, the unexpected water contents (δ(2)H and δ(18)O) in blood plasma of body water may shed light on a novel assessment of renal functions.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22348150 PMCID: PMC3278461 DOI: 10.1371/journal.pone.0032137
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Isotopic values of control subject's blood plasma.
| CS | Sex | Sampling Date | Age | BUN (mg/dL) | Creat (mg/dL) | eGFR (mL/min/1.73 m2) | δ18O (‰) | δ2H (‰) |
|
| ||||||||
| 1 | M | Nov-07 | 67 | −5.72 | −41.2 | |||
| 2 | M | Jul-08 | 55 | −5.56 | −40.4 | |||
| 3 | M | Oct-08 | 43 | −5.78 | −42.6 | |||
| 4 | M | Apr-09 | 29 | −5.67 | −33.6 | |||
| 5 | F | Apr-09 | 27 | −7.67 | −44.3 | |||
| 6 | F | May-09 | 31 | −7.81 | −39.8 | |||
|
| ||||||||
| 7 | F | Dec-09 | 39 | 11.0 | 0.7 | 99.54 | −5.87 | −37.1 |
| 8 | F | Dec-09 | 43 | 15.0 | 0.6 | 116.52 | −4.22 | −31.5 |
| 9 | M | Dec-09 | 45 | 15.0 | 0.7 | 96.62 | −5.02 | −34.5 |
| 10 | M | Dec-09 | 30 | 14.0 | 0.7 | 134.14 | −4.37 | −34.8 |
| 11 | F | Dec-09 | 41 | 7.0 | 0.6 | 117.68 | −4.34 | −38.1 |
| Mean (std.) | ||||||||
| CStotal | 41 (12.1) | −5.63 (1.2) | −38.0 (4.1) | |||||
| CSR | 42 (16.2) | −6.37 (1.1) | −40.3 (3.7) | |||||
| CSF | 40 (5.8) | 12.4 (3.4) | 0.66 (0.05) | 112.9 (15.3) | −4.76 (0.7) | −35.2 (2.6) | ||
The 11 human blood plasma samples (CS-1 to CS-11) were collected from the control subjects with healthy kidney.
All control subjects are inside the country without traveling three months prior to sample.
The blood urea nitrogen (BUN) test is to evaluate the renal function by measuring the amount of nitrogen in the form of urea in blood. The normal level of urea in blood is 7–20 mg/dL.
The creatinine is the metabolite of creatine. The creatinine test is used as an indicator of renal function. The normal level of creatinine in blood is 0.7–1.2 mg/dL for male, and 0.5–1.9 mg/dL for female [48].
The estimation of Glomerular filtration rate, an index of renal function. The eGFR value is calculated based on the MDRD (Modification of Diet in Renal Disease) formula, eGFR = 186×serium creatinine−1.154×age−0.203×(1.212 if black)×(0.742 if female) [49].
The ratio is reported as the δ-notation (‰) relative to the international V-SMOW (Vienna Standard Mean Ocean Water) standard and normalized on the scale that the δ 18O and δ2H of SLAP (Standard Light Antarctic Precipitation) are −55.5‰ and −428‰, respectively [47].
CSR's are human blood plasma samples collected from the control subjects (CS-1 to CS-6) at random. These subjects didn't take the BUN, Creat, and eGFR test.
CSF's are human blood plasma samples collected from the control subjects (CS-7 to CS-11) fasting for 8 hours.
The numbers in the parenthesis are the standard deviations taken all numbers of each group.
Isotopic values of end stage renal disease (ESRD) patient's blood plasma.
| ESRD | Sex | Sampling Date | Age | BUN (mg/dL) | Creat (mg/dL) | eGFR (mL/min/1.73 m2) | Na+ (mmol/L) | K+ (mmol/L) | Cl− (mmol/L) | δ18O (‰) | δ2H (‰) |
|
| |||||||||||
| 1 | F | Sep-09 | 65 | 40.0 | 1.9 | 28.29 | −12.59 | −78.6 | |||
| 2 | M | Sep-09 | 77.0 | 4.8 | 12.24 | −12.55 | −76.6 | ||||
| 3 | F | Sep-09 | 71 | 92.0 | 5.9 | 10.12 | −12.31 | −67.4 | |||
| 4 | M | Sep-09 | 82 | 42.0 | 2.2 | 30.69 | −11.61 | −69.1 | |||
| 5 | M | Sep-09 | 70 | 64.0 | 2.8 | 23.93 | −10.39 | −70.5 | |||
|
| |||||||||||
| 6 | F | Jul-08 | −11.31 | −78.9 | |||||||
| 7 | F | Jul-08 | −11.41 | −82.1 | |||||||
| 8 | F | Mar-09 | 54 | 82.0 | 11.5 | 3.69 | 141 | 4.9 | 96 | −15.95 | −72.3 |
| 9 | M | Mar-09 | 62 | 87.0 | 9.8 | 5.82 | 135 | 6.5 | 97 | −15.08 | −73.8 |
| 10 | M | Mar-09 | 69 | 31.07 | 13.5 | 3.94 | 136 | 4.1 | 94 | −14.37 | −69 |
| 11 | M | Mar-09 | 60 | 69.0 | 12.5 | 4.44 | 140 | 4.5 | 100 | −14.24 | −73.4 |
| 12 | F | Mar-09 | 77 | 38.0 | 5.2 | 8.57 | 139 | 2.4 | 95 | −13.45 | −71.1 |
| 13 | M | Mar-09 | 53 | 80.0 | 11.7 | 4.9 | 137 | 4.9 | 98 | −13.3 | −65.1 |
| 14 | M | Mar-09 | 84 | 55.0 | 9.1 | 5.96 | 135 | 4.4 | 97 | −12.12 | −55.3 |
| 15 | M | Mar-09 | 64 | 82.0 | 9.9 | 5.71 | 134 | 5.2 | 97 | −11.95 | −70.6 |
| 16 | M | Mar-09 | 74 | 113.0 | 10.1 | 5.43 | 137 | 5.8 | 94 | −11.00 | −52.6 |
| 17 | F | Mar-09 | 46 | 73.0 | 10.4 | 4.29 | 135 | 5.4 | 98 | −10.66 | −49.7 |
| 18 | F | Mar-09 | 64 | 70.0 | 8.1 | 5.34 | 125 | 3.6 | 90 | −10.56 | −60.2 |
| 19 | M | Mar-09 | 79 | 65.0 | 9.0 | 6.12 | 133 | 4.5 | 97 | −10.31 | −57.9 |
| 20 | F | Mar-09 | 76 | 51.0 | 7.0 | 6.12 | 136 | 4.2 | 97 | −9.77 | −58.8 |
| 21 | M | Mar-09 | 81 | 51.0 | 8.4 | 6.59 | 138 | 3.1 | 99 | −9.61 | −63.3 |
| 22 | M | Mar-09 | 38 | 120.0 | 16.0 | 3.69 | 138 | 5.0 | 97 | −9.31 | −54.6 |
| 23 | F | Mar-09 | 94 | 86.0 | 6.3 | 6.60 | 128 | 5.1 | 9 | −9.29 | −53.0 |
| 24 | M | Mar-09 | 46 | 85.0 | 11.2 | 5.33 | 135 | 4.4 | 92 | −9.27 | −54.6 |
| 25 | M | Mar-09 | −8.89 | −53.0 | |||||||
| 26 | F | Mar-09 | 55 | 62.0 | 8.6 | 5.15 | 136 | 5.3 | 96 | −8.06 | −56.1 |
| 27 | M | Mar-09 | 85 | 19.0 | 7.9 | 7.00 | 132 | 5.9 | 100 | −7.93 | −45.5 |
| 28 | F | Mar-09 | 77 | 78.0 | 5.7 | 7.71 | 137 | 4.2 | 97 | −7.78 | −49.4 |
| 29 | M | Mar-09 | 63 | 66.0 | 12.5 | 4.38 | 139 | 4.8 | 99 | −7.60 | −45.4 |
| 30 | F | Mar-09 | 60 | 93.0 | 10.0 | 4.26 | 135 | 3.9 | 93 | −5.74 | −48.3 |
| 31 | M | Mar-09 | 86 | 105.0 | 11.7 | 4.44 | 131 | 5.2 | 94 | −5.60 | −41.7 |
| 32 | M | Mar-09 | 66 | 95.0 | 12.3 | 4.42 | 135 | 5.1 | 97 | −5.44 | −40.1 |
| Mean (std.) | |||||||||||
| ESRDnHD | 72 (7.1) | 63.0 (22.4) | 3.5 (1.7) | 21.05 (9.36) | −11.89 (0.9) | −72.4) (4.9) | |||||
| ESRDHD | 67 (14) | 73.2 (24.6) | 9.9 (2.6) | 5.41 (1.27) | 135(4) | 5.0(1.0) | 92(18) | −10.37 (2.9) | −59.1 (11.5) | ||
32 human blood plasma samples were collected from ESRD (End stage renal disease) patients, fasting for 8 hours, and are subjected into two groups, ESRDnHD (end stage renal disease yet with no haemodialysis treatment) and ESRDHD (end stage renal disease with receiving haemodialysis treatment).
The BUN, Creat, and eGFR test, all is the indicator for renal function; see Table 1 footnotes c, d, and e.
The concentration of sodium in blood. The normal level of sodium in blood is 135–140 mmol/L.
The concentration of potassium in blood. The normal blood potassium level is 3.5–5 mmol/L.
The concentration of chloride in blood. The normal range for chloride in blood is 98–108 mmol/L.
The isotope ratio is reported as the δ-notation (‰), see details in Table 1 footnotes c and d.
ESRDnHD samples (ESRD-1 to ESRD-5) were collected from the ESRD patients who have not yet been the haemodialysis treatment. The ESRDnHD did not perform the monovalent ion test.
ESRDHD samples (ESRD-6 to ESRD-32) were collected from the ESRD patients who are receiving haemodialysis over 6 months. These samples were collected right before the ESRD patients to receive the haemodialysis.
The numbers in the parenthesis are the standard deviations taken all numbers of each group.
Isotopic values of diabetes (DB) patient's blood plasma.
| DB | Sex | Age | Sampling Date | Creatinine (mg/dL) | eGFR (mL/min/1.73 m2) | glucose (mg/dL) | δ18O (‰) | δ2H (‰) |
| 1 | F | 61 | Dec-09 | 0.6 | 108.38 | 198 | −4.11 | −36.1 |
| 2 | F | 74 | Dec-09 | 0.5 | 128.54 | 102 | −4.25 | −28.1 |
| 3 | F | 76 | Dec-09 | 0.6 | 103.58 | 153 | −4.14 | −38.7 |
| 4 | F | 70 | Dec-09 | 0.8 | 75.81 | 181 | −3.50 | −29.3 |
| 5 | M | 61 | Dec-09 | 1.0 | 81.01 | 170 | −4.18 | −38.2 |
| Mean (std.) | 68.4 (7.1) | 0.7 (0.2) | 99.46 (21.46) | 160.8 (36.7) | −4.04 (0.3) | −34.08 (5.0) | ||
The DB blood plasma samples (DB-1 to DB-5) were collected from the diabetes patients, fasting for 8 hours.
The plasma creatinine concentration, an indicator of renal function.
The estimation of Glomerular filtration rate, an index of renal function. See Table 1 footnote e for details.
Fasting blood glucose level.
The isotope ratio is reported as the δ-notation (‰), see details in Table 1 footnotes c and d.
The numbers in the parenthesis are the standard deviations taken all numbers of DB.
Figure 1The stable isotopic ratios of hydrogen (δ2H) and oxygen (δ18O) in human blood plasma.
Squares represent the distributions of the δ2H and δ18O of human blood plasma, colored by group: CSR in cyan, CSF in blue, ESRDnHD in red, ESRDHD in yellow, and DB in green. The colored circles are the clusters obtained by applying the k-means analysis with a preset of 4 clusters to the all datasets. The blue circle comprises all CSF (100%) and all DB (100%). The cyan circle is constituted of most CSR (83%) and several ESRDHD (22%). The yellow circle encloses about half of the ESRDHD data (44%). The ESRDnHD (100%) is clustered in the red circle along with 9 ESRDHD data points (33%). The triangle denotes the centroid of each cluster.
Figure 2A comparison of stable isotopic water in human blood plasma and monthly mean precipitation in 2000–2010 at Taipei, Taiwan.
(A) The mean values of Taipei precipitation in March, July and September from the past 11 years are idiosyncrasies to the δ18O in blood plasma of the ESRDnHD (100%) and the ESRDHD (100%). This occurrence is observed in the DB and the CSF. 50% of the CSR are corresponding to the precipitation. (B) Both δ2H and δ18O in blood plasma of the ESRDnHD, ESRDHD, and CSR are observed in a comparable manner of the monthly precipitation. None of the CSF is corresponding to the precipitation. The δ18O and δ2H in blood plasma are indicated by squares, colored as in figure 1. The mean δ18O and δ2H in precipitation are indicated by circles, connected by gray lines. Error bars (black vertical lines connected by breaks) represent the standard deviation of the mean.
Figure 3The stable isotopes of monthly precipitation in Taipei, Taiwan and in Cluj-Napoca, Romania.
Shown is the estimated stable isotope of monthly precipitation, generated by using algorithm, developed by Bowen et. al. [12], [37]. The square denotes the estimated isotope of monthly precipitation in Taipei with settings of latitude 25°, longitude 121.5°, and altitude 10 m. The circle denotes the estimated isotope of monthly precipitation in Cluj-Napoca with settings of latitude 46.7°, longitude 23.6°, and altitude 335 m.